Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care
- PMID: 30880000
- PMCID: PMC6522934
- DOI: 10.1016/j.esxm.2019.01.004
Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care
Abstract
Introduction: The importance of erectile dysfunction (ED) diagnosis and treatment has been highlighted since the early 2000s. However, nearly 20 years after the first phosphodiesterase 5 inhibitor (PDE5i) was marketed, underdiagnosis and undertreatment of ED in the primary health care setting may still be present.
Aim: To assess the relative frequency of patients who are medically treated for ED before referral to specialized urology care. The secondary objectives were to evaluate possible reasons for non-treatment prior to referral and other signs of undertreatment, namely cardiovascular risk assessment and antihypertensive treatment.
Methods: 200 male patients referred for ED to specialist urology care by general practitioners were screened after consent between January 2016-December 2018. A full standardized medical and sexual history were taken. Previous medical treatment of ED, namely pharmacologic name and dosages, and cardiovascular risk factors were noted.
Main outcome measures: Of the 115 included patients, only 33.9% of patients had already taken PDE5i before referral, and none had taken alprostadil by intracavernous route.
Results: The mean patient age was 58.68 ± 10.01 years old. Only 45.2% had been prescribed the highest dose of PD5i. From the remaining untreated patients, only 19.7% had ≥3 cardiovascular risk factors, including 5.6% of patients who also presented moderate-to-severe stable or unstable angina requiring a stress test or cardiology assessment before treatment. Regarding the 54 patients with medical history of arterial hypertension, 43.4% and 30.2% were treated for hypertension with a diuretic and a beta blocker, respectively.
Conclusion: More focus on the primary healthcare continuous medical education regarding sexual dysfunction, namely ED, is needed because major undertreatment of ED is still present because low prescription of PD5i before referral is noted. Morgado A, Moura ML, Dinis P, et al. Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care. Sex Med 2019;7:177-183.
Keywords: Erectile Dysfunction; General Practitioner; Primary Health Care; Undertreatment.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial Comment: Misdiagnosis And Undertrea-tment Of Erectile Dysfunction In The Portuguese Primary Health Care.Int Braz J Urol. 2020 Nov-Dec;46(6):1094-1095. doi: 10.1590/S1677-5538.IBJU.2020.06.06. Int Braz J Urol. 2020. PMID: 32822138 Free PMC article. No abstract available.
Similar articles
-
An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.J Sex Med. 2019 Oct;16(10):1541-1546. doi: 10.1016/j.jsxm.2019.07.013. Epub 2019 Aug 20. J Sex Med. 2019. PMID: 31444103 Free PMC article.
-
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.Sex Med Rev. 2019 Jul;7(3):430-441. doi: 10.1016/j.sxmr.2018.11.007. Epub 2019 Jan 30. Sex Med Rev. 2019. PMID: 30711478
-
Erectile Dysfunction Medications and Treatment for Cardiometabolic Risk Factors: A Pharmacoepidemiologic Study.J Sex Med. 2017 Dec;14(12):1597-1605. doi: 10.1016/j.jsxm.2017.10.063. J Sex Med. 2017. PMID: 29198514
-
Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.J Sex Med. 2014 Oct;11(10):2546-53. doi: 10.1111/jsm.12647. Epub 2014 Jul 24. J Sex Med. 2014. PMID: 25059314
-
[Sex, erectile dysfunction, and the heart: a growing problem].Herz. 2003 Jun;28(4):284-90. doi: 10.1007/s00059-003-2478-8. Herz. 2003. PMID: 12825143 Review. German.
Cited by
-
Quality and benefits of the erectile dysfunction information on websites, social-media, and applications.Int J Impot Res. 2024 Nov;36(7):688-692. doi: 10.1038/s41443-023-00725-1. Epub 2023 Jun 27. Int J Impot Res. 2024. PMID: 37369784 Review.
-
Quality of Life, Sexual Functioning and Chronic Disease: A Comparative Study with Portuguese Women without Chronic Disease, and Women with Diabetes Type 1 and 2, and Arterial Hypertension.Int J Sex Health. 2021 Dec 15;34(2):209-220. doi: 10.1080/19317611.2021.2015038. eCollection 2022. Int J Sex Health. 2021. PMID: 38596520 Free PMC article.
-
Prevalence, Comorbidities, and Risk Factors of Erectile Dysfunction: Results from a Prospective Real-World Study in the United Kingdom.Int J Clin Pract. 2022 Mar 20;2022:5229702. doi: 10.1155/2022/5229702. eCollection 2022. Int J Clin Pract. 2022. PMID: 35693549 Free PMC article.
-
Spanish Cross-Cultural Validation of the Electronic Version of the International Index of Erectile Function-5 (IIEF-5).Int J Environ Res Public Health. 2022 Mar 7;19(5):3115. doi: 10.3390/ijerph19053115. Int J Environ Res Public Health. 2022. PMID: 35270819 Free PMC article.
-
General practitioners' self-reported competence in the management of sexual health issues - a web-based questionnaire study from Finland.Scand J Prim Health Care. 2021 Sep;39(3):279-287. doi: 10.1080/02813432.2021.1934983. Epub 2021 Jul 13. Scand J Prim Health Care. 2021. PMID: 34256654 Free PMC article.
References
-
- Laumann E.O., Paik A., Rosen R.C. The epidemiology of erectile dysfunction: Results from the National Health and Social Life Survey. Int J Impot Res. 1999;11(Suppl. 1):S60–S64. - PubMed
-
- Guo W., Liao C., Zou Y. Erectile dysfunction and risk of clinical cardiovascular events: A meta-analysis of seven cohort studies. J Sex Med. 2010;7:2805–2816. - PubMed
-
- Fan Y., Hu B., Man C. Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: A meta-analysis of cohort studies. World J Urol. 2018;36:1681–1689. - PubMed
-
- Montorsi F., Briganti A., Salonia A. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol. 2003;44:360–364. discussion 364-365. - PubMed